NEW YORK (GenomeWeb) – Roche will acquire the remainder of Foundation Medicine for $2.4 billion in cash, the companies said today.
Roche already owned about 57 percent of Foundation's outstanding common stock, following a tender offer in 2015.
NEW YORK (GenomeWeb) – Roche will acquire the remainder of Foundation Medicine for $2.4 billion in cash, the companies said today.
Roche already owned about 57 percent of Foundation's outstanding common stock, following a tender offer in 2015.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.